Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc. > Wednesday Trading

<< Previous

Bullboard Posts

Next >>

Comment by CASHEAGLEon Dec 18, 2021 12:56am

123 Views

Post# 34242912

RE:RE:Wednesday Trading

AGN

is going to be $100

m once it hits NAsdaq...that s is just the valuation and
chris
Moreai has done this before..He works with promoy=ters and gets results..He too AGN from $.02 namd tarded 1B agn shares on covid fever he qalmsot nlew $12M in phqse i on covid with zero to show.

But he isno wonto a cough del that is going to be $1..it might repets his oast sucess in d=getting f=da approvals..he i horsento bet on..buy aat $ and sell at

4.50 om=n his last sucess

4.04